Related Experiment Video
Updated: Apr 15, 2026

04:45
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
4.6K
Personalizing surgical margins in retroperitoneal sarcomas
Dario Callegaro1, Marco Fiore, Alessandro Gronchi
1Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian, 1 - 20133 Milan, Italy.
Expert Review of Anticancer Therapy
|March 24, 2015
Summary
Retroperitoneal sarcomas vary in behavior. High-quality surgery is crucial for all subtypes, especially those where local control impacts prognosis, to improve oncological outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Sarcoma Research
Background:
- Retroperitoneal sarcomas encompass diverse subtypes with distinct clinical behaviors.
- Well-differentiated liposarcomas exhibit indolent biology but high local recurrence rates.
- Dedifferentiated liposarcomas and leiomyosarcomas present unique challenges regarding recurrence and metastasis.
Purpose of the Study:
- To analyze the differential behavior of retroperitoneal sarcoma subtypes.
- To emphasize the critical role of surgical quality in oncological outcomes.
- To highlight the importance of frontline extended surgical approaches for specific subtypes.
Main Methods:
- Review of clinical behaviors and prognoses of different retroperitoneal sarcoma subtypes.
- Analysis of treatment-related factors influencing oncological outcomes.
- Evaluation of the impact of surgical approach on local control and prognosis.
Main Results:
- Local recurrence is a significant issue for well-differentiated and dedifferentiated liposarcomas.
- Metastatic risk in dedifferentiated liposarcomas correlates with histological features.
- Hematogenous spread is a key prognostic factor for leiomyosarcomas, with lower local recurrence rates.
Conclusions:
- Surgical quality is the sole treatment-related factor improving oncological outcomes in retroperitoneal sarcomas.
- An aggressive frontline surgical strategy is essential for subtypes where local control directly influences prognosis.
- Tailoring surgical approaches based on sarcoma subtype is critical for optimizing patient outcomes.

